WOK
WORK Medical·NASDAQ
--
--(--)
--
--(--)
9.70 / 10
Outperform
Fundamental analysis rates the stock Outperform with a 9.7/10 score. Key strengths include high Net profit/Total operating revenue (‑12.19%) and EBIT/Revenue (‑7.72%) scores, strong ROA and asset margins. Weaknesses arise from negative Net profit/Total profit and cash‑flow ratios.
Analysis Checks(4/6)
ROA (%)
Value-3.46
Score2/3
Weight55.59%
1M Return0.64%
Value-3.46
Score2/3
Weight55.59%
1M Return0.64%
Annualized net profit margin on total assets (%)
Value-3.46
Score2/3
Weight55.59%
1M Return0.64%
Value-3.46
Score2/3
Weight55.59%
1M Return0.64%
Net profit / Total operating revenue (%)
Value-12.19
Score2/3
Weight112.87%
1M Return1.26%
Value-12.19
Score2/3
Weight112.87%
1M Return1.26%
Net cash flow from operating activities / Operating revenue (%)
Value63.40
Score1/3
Weight-99.14%
1M Return-1.35%
Value63.40
Score1/3
Weight-99.14%
1M Return-1.35%
EBIT / Total operating revenue (%)
Value-7.72
Score3/3
Weight141.89%
1M Return1.53%
Value-7.72
Score3/3
Weight141.89%
1M Return1.53%
Net profit / Total profit (%)
Value111.00
Score1/3
Weight-166.80%
1M Return-2.39%
Value111.00
Score1/3
Weight-166.80%
1M Return-2.39%
ROA (%)
Value-3.46
Score2/3
Weight55.59%
1M Return0.64%
Value-3.46
Score2/3
Weight55.59%
1M Return0.64%
Net cash flow from operating activities / Operating revenue (%)
Value63.40
Score1/3
Weight-99.14%
1M Return-1.35%
Value63.40
Score1/3
Weight-99.14%
1M Return-1.35%
Annualized net profit margin on total assets (%)
Value-3.46
Score2/3
Weight55.59%
1M Return0.64%
Value-3.46
Score2/3
Weight55.59%
1M Return0.64%
EBIT / Total operating revenue (%)
Value-7.72
Score3/3
Weight141.89%
1M Return1.53%
Value-7.72
Score3/3
Weight141.89%
1M Return1.53%
Net profit / Total operating revenue (%)
Value-12.19
Score2/3
Weight112.87%
1M Return1.26%
Value-12.19
Score2/3
Weight112.87%
1M Return1.26%
Net profit / Total profit (%)
Value111.00
Score1/3
Weight-166.80%
1M Return-2.39%
Value111.00
Score1/3
Weight-166.80%
1M Return-2.39%
Is WOK fundamentally strong?
- WOK scores 9.70/10 on fundamentals and holds a Discounted valuation at present. Backed by its -5.76% ROE, -12.19% net margin, -1.90 P/E ratio, 0.10 P/B ratio, and 85.19% earnings growth, these metrics solidify its Outperform investment rating.
